| Group . | Median (IQR) (mg/l) . | P-value* . |
|---|---|---|
| Relapse (n = 12) | ||
| 6 months before relapse | 78 (33–91) | 0.22 |
| Relapse time | 126 (79.8–198) | |
| End of follow-up | 67 (44–117.3) | |
| Two times comparison for relapse | ||
| 6 months before relapse versus relapse time | 0.18 | |
| Relapse time versus end of follow-up | 0.016 | |
| 6 months before relapse versus end of follow-up | 0.92 | |
| Non-relapse (n = 25) | ||
| Before surgery | 75 (55.3–156) | 0.003 |
| End of follow-up | 52 (34–75) | |
| Group . | Median (IQR) (mg/l) . | P-value* . |
|---|---|---|
| Relapse (n = 12) | ||
| 6 months before relapse | 78 (33–91) | 0.22 |
| Relapse time | 126 (79.8–198) | |
| End of follow-up | 67 (44–117.3) | |
| Two times comparison for relapse | ||
| 6 months before relapse versus relapse time | 0.18 | |
| Relapse time versus end of follow-up | 0.016 | |
| 6 months before relapse versus end of follow-up | 0.92 | |
| Non-relapse (n = 25) | ||
| Before surgery | 75 (55.3–156) | 0.003 |
| End of follow-up | 52 (34–75) | |
P-values <0.017 were considered statistically significant for ‘two times comparison for relapse’.
IQR: interquartile range.
| Group . | Median (IQR) (mg/l) . | P-value* . |
|---|---|---|
| Relapse (n = 12) | ||
| 6 months before relapse | 78 (33–91) | 0.22 |
| Relapse time | 126 (79.8–198) | |
| End of follow-up | 67 (44–117.3) | |
| Two times comparison for relapse | ||
| 6 months before relapse versus relapse time | 0.18 | |
| Relapse time versus end of follow-up | 0.016 | |
| 6 months before relapse versus end of follow-up | 0.92 | |
| Non-relapse (n = 25) | ||
| Before surgery | 75 (55.3–156) | 0.003 |
| End of follow-up | 52 (34–75) | |
| Group . | Median (IQR) (mg/l) . | P-value* . |
|---|---|---|
| Relapse (n = 12) | ||
| 6 months before relapse | 78 (33–91) | 0.22 |
| Relapse time | 126 (79.8–198) | |
| End of follow-up | 67 (44–117.3) | |
| Two times comparison for relapse | ||
| 6 months before relapse versus relapse time | 0.18 | |
| Relapse time versus end of follow-up | 0.016 | |
| 6 months before relapse versus end of follow-up | 0.92 | |
| Non-relapse (n = 25) | ||
| Before surgery | 75 (55.3–156) | 0.003 |
| End of follow-up | 52 (34–75) | |
P-values <0.017 were considered statistically significant for ‘two times comparison for relapse’.
IQR: interquartile range.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
